ALEXANDRIA, Va., April 29, 2015 /PRNewswire-USNewswire/ -- The American Diabetes Association will present the Harold Rifkin Award for Distinguished International Service in the Cause of Diabetes to Carl Erik Mogensen, MD. Sponsored by Janssen Pharmaceutical Companies of Johnson & Johnson, the Harold Rifkin Award honors individual outstanding service in the cause of diabetes that has been performed with an international perspective and with international impact. Dr. Mogensen will be recognized with this honor at the Association's 75th Scientific Sessions® taking place June 5-9, 2015, at the Boston Convention and Exhibition Center in Boston.
Currently Professor Emeritus of Medicine, Aarhus University Hospital, Aarhus, Denmark, Dr. Mogensen's career is distinguished for extensive studies of microalbuminuria, which led to a new classification of kidney disease in diabetes. Known internationally for his contributions at the interface between clinical science and physiology, his studies revealed for the first time that microalbuminuria predicts overt renal disease and, in type 2 diabetes, predicts early mortality. His efforts influenced changes in clinical practice across the globe by demonstrating that antihypertensive therapy could delay, and possibly prevent, the loss of kidney function.
Indicating his significant contributions to the field, Dr. Mogensen's nearly 500 publications have been cited more than 30,500 times with an h-index of 82. Dr. Mogensen has delivered nearly 200 invited lectures across the world and has provided a lifetime of service to numerous international diabetes-related organizations, including the American Diabetes Association, the European Association for the Study of Diabetes, and the International Society of Nephrology.
More than 14,000 top scientists, physicians and other health care professionals from around the world will share the latest cutting-edge research and learn the most up-to-date information on prevention, treatment and care, at the Association's Scientific Sessions.
The American Diabetes Association is leading the fight to Stop Diabetes® and its deadly consequences and fighting for those affected by diabetes. The Association funds research to prevent, cure and manage diabetes; delivers services to hundreds of communities; provides objective and credible information; and gives voice to those denied their rights because of diabetes. For the past 75 years, our mission has been to prevent and cure diabetes and to improve the lives of all people affected by diabetes. For more information please call the American Diabetes Association at 800-DIABETES (800-342-2383) or visit diabetes.org. Information from both these sources is available in English and Spanish.